https://scholars.lib.ntu.edu.tw/handle/123456789/612559
標題: | A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma | 作者: | Qin S. Chan S.L. Sukeepaisarnjaroen W. Han G. Choo S.P. Sriuranpong V. Pan H. Yau T. Guo Y. Chen M. Ren Z. Xu J. Yen C.-J. ZHONG-ZHE LIN Manenti L. Gu Y. Sun Y. Tiedt R. Hao L. Song W. Tanwandee T. |
公開日期: | 2019 | 出版社: | SAGE Publications Inc. | 卷: | 11 | 來源出版物: | Therapeutic Advances in Medical Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076565560&doi=10.1177%2f1758835919889001&partnerID=40&md5=0dc5aeb27bbe0cae43b92c9a0f0d4c28 https://scholars.lib.ntu.edu.tw/handle/123456789/612559 |
ISSN: | 1758-8340 | DOI: | 10.1177/1758835919889001 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。